Log In
Saturday 24th March 2018

Cholesterol Drug Warning

29th October 2008

Cholesterol-lowering drugs may cause prostate cancers to be missed, experts warned.


A study found men taking statins experienced a significant drop in blood levels of a prostate specific antigen (PSA) tests.


A "healthy" PSA result from a man on statins may mean his prostate cancer goes undetected, said researchers.


Studies have suggested statins may protect against prostate cancer or slow the disease.


However, just because statins lower PSA it does not necessarily mean they have a biological effect on prostate cancer.


PSA is known to be an unreliable indicator.


A definitive diagnosis requires a biopsy - removal of a tissue sample for analysis - after an abnormal PSA result.


The warning was issued by researchers led by Dr Stephen Freedland from Duke University School of Medicine in Durham, New Carolina, US.


They wrote in the Journal of the National Cancer Institute.

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: Cholesterol Drug Warning
Author: Anne Waller
Article Id: 8954
Date Added: 29th Oct 2008


Birmingham Post

Recent Related Articles

Prescription drug addiction to be reviewed

New early warning system to be rolled out across NHS


Add to scrapbook
Show Comments
Add comment
Find all related articles

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2018